These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 16638062

  • 1. [Skin ulceration after leflunomide treatment in two patients with rheumatoid arthritis].
    Jakob A, Porstmann R, Rompel R.
    J Dtsch Dermatol Ges; 2006 Apr; 4(4):324-7. PubMed ID: 16638062
    [Abstract] [Full Text] [Related]

  • 2. Leflunomide-associated skin ulceration.
    McCoy CM.
    Ann Pharmacother; 2002 Jun; 36(6):1009-11. PubMed ID: 12022903
    [Abstract] [Full Text] [Related]

  • 3. [Alopecia areata secondary to the use of leflunomide in patients with rheumatoid arthritis: a case report and literature review].
    Molina Molina MI, Pinochet Paiva CM, Quezada Morales JI.
    Medwave; 2015 Dec 30; 15(11):e6350. PubMed ID: 26819061
    [Abstract] [Full Text] [Related]

  • 4. Leflunomide treatment in elderly patients with rheumatoid or psoriatic arthritis: retrospective analysis of safety and adherence to treatment.
    Alivernini S, Mazzotta D, Zoli A, Ferraccioli G.
    Drugs Aging; 2009 Dec 30; 26(5):395-402. PubMed ID: 19552491
    [Abstract] [Full Text] [Related]

  • 5. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
    Bao C, Chen S, Gu Y, Lao Z, Ni L, Yu Q, Xu J, Li X, Liu J, Sun L, He P, Ma J, Xu S, Ding C.
    Chin Med J (Engl); 2003 Aug 30; 116(8):1228-34. PubMed ID: 12935395
    [Abstract] [Full Text] [Related]

  • 6. Disseminated cutaneous and visceral Kaposi sarcoma in a woman with rheumatoid arthritis receiving leflunomide.
    Lee SY, Jo YM, Chung WT, Kim SH, Kim SY, Roh MS, Lee SW.
    Rheumatol Int; 2012 Apr 30; 32(4):1065-8. PubMed ID: 20063189
    [Abstract] [Full Text] [Related]

  • 7. [Pleuro-pericarditis developed under a leflunomide therapy].
    Vandenbos F, Figueredo M, Tarhini A, Ribière J.
    Rev Pneumol Clin; 2015 Feb 30; 71(1):57-9. PubMed ID: 25457216
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis.
    Mroczkowski PJ, Weinblatt ME, Kremer JM.
    Clin Exp Rheumatol; 1999 Feb 30; 17(6 Suppl 18):S66-8. PubMed ID: 10589360
    [Abstract] [Full Text] [Related]

  • 10. Leflunomide and rheumatoid arthritis: new preparation. Neither the safest nor the most effective slow-acting antirheumatic drug.
    Prescrire Int; 2001 Apr 30; 10(52):36-9. PubMed ID: 11718154
    [Abstract] [Full Text] [Related]

  • 11. Leflunomide in active rheumatoid arthritis: a prospective study in daily practice.
    Van Roon EN, Jansen TL, Mourad L, Houtman PM, Bruyn GA, Griep EN, Wilffert B, Tobi H, Brouwers JR.
    Br J Clin Pharmacol; 2004 Jun 30; 57(6):790-7. PubMed ID: 15151525
    [Abstract] [Full Text] [Related]

  • 12. Safety evaluation of leflunomide in rheumatoid arthritis.
    Keen HI, Conaghan PG, Tett SE.
    Expert Opin Drug Saf; 2013 Jul 30; 12(4):581-8. PubMed ID: 23668332
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative study of the clinical efficacy of four DMARDs (leflunomide, methotrexate, cyclosporine, and levamisole) in patients with rheumatoid arthritis.
    Popovic M, Stefanovic D, Pejnovic N, Popovic R, Glisic B, Obradovic S, Dimitrijevic M.
    Transplant Proc; 1998 Dec 30; 30(8):4135-6. PubMed ID: 9865325
    [No Abstract] [Full Text] [Related]

  • 16. [Efficacy of leflunomide].
    Hirohata S.
    Nihon Rinsho; 2002 Dec 30; 60(12):2357-63. PubMed ID: 12510362
    [Abstract] [Full Text] [Related]

  • 17. Leflunomide discontinuation in rheumatoid arthritis and influence of associated disease-modifying anti-rheumatic drugs: a survival analysis.
    Rodriguez-Rodriguez L, Jover-Jover JA, Fontsere O, Peña-Blanco RC, León L, Fernández-Gutierrez B, Abásolo L.
    Scand J Rheumatol; 2013 Dec 30; 42(6):433-6. PubMed ID: 23742043
    [Abstract] [Full Text] [Related]

  • 18. Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses.
    Behrens F, Koehm M, Burkhardt H.
    Curr Opin Rheumatol; 2011 May 30; 23(3):282-7. PubMed ID: 21427581
    [Abstract] [Full Text] [Related]

  • 19. Risk factors of severe infections in patients with rheumatoid arthritis treated with leflunomide.
    Yoo HG, Yu HM, Jun JB, Jeon HS, Yoo WH.
    Mod Rheumatol; 2013 Jul 30; 23(4):709-15. PubMed ID: 22791271
    [Abstract] [Full Text] [Related]

  • 20. Treatment with either leflunomide or adalimumab reduces anaemia in patients with rheumatoid arthritis.
    Pereira ICP, Sousa NCF, Pereira DMS, Mendes SJF, Muniz TF, Colares VLP, Silva BLR, Monteiro CRAV, Martins MMRS, Fernandes AMR, Fernandes ES.
    An Acad Bras Cienc; 2018 Aug 30; 90(2 suppl 1):2161-2166. PubMed ID: 29947664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.